News

BioSpace23h
Cullinan Bets $700M+ in Back-Heavy China Deal for Autoimmune T Cell Engager
Genrix’s velinotamig complements Cullinan’s own pipeline, according to William Blair, which added that the deal will put ...
Pharmabiz23h
AnaptysBio announces positive results from phase 2b trial of rosnilimab to treat rheumatoid arthritis
AnaptysBio announces positive results from phase 2b trial of rosnilimab to treat rheumatoid arthritis: San Diego Thursday, June 5, 2025, 18:00 Hrs [IST] AnaptysBio, Inc., a clinic ...
Vigil Neuroscience: ALSP Data Doesn't Deliver, But Sanofi Purchase Remains Intact
Sanofi's $470M Vigil Neuroscience, Inc. acquisition highlights VG-3927's potential in Alzheimer's. Click here to find out why ...
Le Lézard10h
Prime Biome Reviews: DOCTOR Breaks Down Shocking June 2025 Findings - Is This The Gut & Skin Microbiome Reset Everyone's Suddenly Talking About?
Update: Prime Biome Reviews Reveal Groundbreaking Gut Microbiome, Skin Barrier, and Dysbiosis Correction Benefits Backed by New Clinical Findings WASHINGTON, PA / ACCESS Newswire / June 5, 2025 / ...